Research & Innovation
Using our antibody expertise to transform how cancer is treated
As a leader in the discovery and development of antibody therapeutics, we are inspired by nature, passionate about innovation and driven by data. Our commitment to patients pushes us to use our antibody biology expertise to pursue and produce differentiated, next-generation cancer treatments.
Our research and innovation teams consist of a strong antibody discovery engine connecting our antibody platform technologies with our target and disease biology knowledge. This synergy is the lifeblood of our R&D organization, where our creations enter clinical development.
Leveraging the power of translational research to create truly personalized medicines
We aim to invent, develop and commercialize differentiated antibody-based products, which can be utilized in a modular fashion to create unique and tailored therapeutics to transform cancer treatments.
Our translational research integrates deep insights on patients, diseases, products and antibody modalities to:
- Provide strong biological understanding of our therapeutic products to help drive clinical development decision making
- Generate sophisticated scientific insights by utilizing innovative computational approaches to integrate translational and clinical data
- Understand the biology of our products, and patients, to match the right drug with the right patients
- Bring novel scientific findings back to our discovery portfolio
Our differentiated translational research capabilities, which leverage biomarkers and companion diagnostics, are bringing us closer to delivering antibody therapeutics so that the right medicine reaches the right patient at the right dose.
Innovation for the future
We are developing next-generation technologies
Turning insights into medicine
See the results of innovation that is
rooted in science.
Driven by data
Each of our decisions and advancements are fueled by data